Cargando…

Ocrelizumab: Coronavirus disease-2019 : 15 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897120/ http://dx.doi.org/10.1007/s40278-022-11159-3

Ejemplares similares

Ocrelizumab: Prolonged severe acute respiratory syndrome Coronavirus-2 infection: case report
Publicado: (2022)

Ocrelizumab/rituximab: Various toxicities: 6 case reports
Publicado: (2021)

Immunosuppressants: Coronavirus-2019 infection: 15 case reports
Publicado: (2020)

Ocrelizumab/rituximab: COVID-19 infection: 2 case reports
Publicado: (2021)

Alemtuzumab/natalizumab/ocrelizumab: COVID-19: 3 case reports
Publicado: (2021)

Ocrelizumab: SARS-CoV-2 pneumonia: 2 case reports
Publicado: (2020)

Ocrelizumab/tozinameran interaction: Impaired vaccine response: 4 case reports
Publicado: (2021)

Ocrelizumab-Induced Severe Colitis
por: Lee, Hsing Hwa, et al.
Publicado: (2020)

Ocrelizumab/rituximab: SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech/ocrelizumab: Vaccine failure: case report
Publicado: (2021)

Antineoplastics: Coronavirus disease 2019: case report
Publicado: (2022)

Antineoplastics: Coronavirus disease-2019: case report
Publicado: (2020)

Immunosuppressants: Coronavirus disease-2019: case report
Publicado: (2020)

Prednisone: Coronavirus disease 2019: case report
Publicado: (2020)

Dual biologic therapy with ocrelizumab for multiple sclerosis and vedolizumab for Crohn’s disease: A case report and review of literature
por: Au, Michael, et al.
Publicado: (2022)

Immunosuppressants: Coronavirus disease of 2019: 3 case reports
Publicado: (2022)

Immunosuppressants: Coronavirus disease 2019: 4 case reports
Publicado: (2020)

Corticosteroids/immunosuppressants: Coronavirus disease 2019: case report
Publicado: (2020)

Sintilimab: Aggravation of Coronavirus disease 2019: case report
Publicado: (2021)

Coronavirus disease 2019 and dengue: two case reports
por: Hilmy, Abdullah Isneen, et al.
Publicado: (2021)

Multiple drugs: Coronavirus disease-2019: case report
Publicado: (2021)

Severe late‐onset neutropenia induced by ocrelizumab in a multiple sclerosis patient: A case report
por: Rauniyar, Robin, et al.
Publicado: (2022)

Severe rebound after cessation of fingolimod treated with ocrelizumab with coincidental transient aggravation: report of two cases
por: Schmidt, Stephan, et al.
Publicado: (2019)

Ocrelizumab-induced inflammatory bowel disease-like illness characterized by esophagitis and colitis
por: Barnes, Alex, et al.
Publicado: (2021)

Coronavirus disease 2019 presenting as psychosis: a case report
por: Lovi, Nyanyuie Kodjo, et al.
Publicado: (2022)

Natalizumab: Coronavirus disease-2019 infection: 6 case reports
Publicado: (2022)

Encephalomyelitis associated with coronavirus disease 2019: a case report
por: Estiasari, Riwanti, et al.
Publicado: (2022)

Pheochromocytoma triggered by coronavirus disease 2019: a case report
por: Naghshineh, Hoda, et al.
Publicado: (2022)

Adrenal insufficiency in coronavirus disease 2019: a case report
por: Heidarpour, Maryam, et al.
Publicado: (2020)

Alemtuzumab/methylprednisolone: Coronavirus disease-2019: 2 case reports
Publicado: (2020)

Belatacept: Coronavirus disease 2019 (COVID-19): case report
Publicado: (2020)

Cytarabine/daunorubicin: Coronavirus disease-2019 pneumonia: case report
Publicado: (2021)

Doxorubicin: Coronavirus disease 2019 (COVID-19): case report
Publicado: (2021)

Multiple drugs: Coronavirus disease 2019: 8 case reports
Publicado: (2021)

Multiple drugs: Coronavirus disease 2019: 25 case reports
Publicado: (2021)

Multiple drugs: Coronavirus disease-2019: 5 case reports
Publicado: (2021)

Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
por: Vališ, Martin, et al.
Publicado: (2020)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Death of a neonate with suspected coronavirus disease 2019 born to a mother with coronavirus disease 2019 in Iran: a case report
por: Rashidian, Tayebeh, et al.
Publicado: (2020)

Coronavirus disease 2019 on routine testing in eclampsia: a case report
por: Kalsar, Pradip, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1s11h7euj8ks4lpictv12n4h7q